Chemogenomics

From Wikipedia, the free encyclopedia

Chemogenomics can be defined as a genomic response to chemical compounds. The goal is the rapid identification of novel drugs and drug targets embracing multiple early phase drug discovery technologies ranging from target identification and validation, over compound design and chemical synthesis to biological testing and ADME profiling.

[edit] See also

• Genomics
  • Structural genomics
  • Pharmacogenetics
  • Pharmacogenomics
  • Toxicogenomics
• Bioinformatics
• Cheminformatics
  • Computational chemistry
  • Molecular modelling
  • QSAR
• Proteochemometrics

[edit] References

• Chemogenomics in Drug Discovery: A Medicinal Chemistry Perspective, H. Kubinyi (Editor), G. Müller (Editor), R. Mannhold (Series Editor), G. Folkers (Series Editor), Wiley-VCH, 2004.ISBN 3-527-30987-X

[edit] External links

• Kubinyi's slides
• Nature chemical genomics gateway

Topics in Medicinal Chemistry
ADME | Bioavailability | Chemogenomics | Drug Design | Drug Discovery | Enzyme Inhibition | Mechanism of Action | New Chemical Entity | Pharmacodynamics | Pharmacokinetics | Pharmacology | Pharmacophore | Quantitative Structure-Activity Relationship

Genomics topics

Genome project | Glycomics | Human Genome Project | Proteomics

Chemogenomics | Structural genomics | Pharmacogenetics | Pharmacogenomics | Toxicogenomics

Bioinformatics | Cheminformatics | Systems biology